One study showed fatal toxicity shortly after the infusion of ERBB2/HER2- (a member of human epidermal growth factor receptor frequently overexpressed in many cancers) targeted CAR T cells, which was caused by the recognition and killing of ERBB2-positive cells expressed at low density on the lung endothelium and epithelium (72). This evidence concerns the gene ERBB2 and cancer.